SenesTech Inc. (SNES)
1.77
-0.03 (-1.67%)
At close: Apr 02, 2025, 3:59 PM
1.81
2.27%
Pre-market: Apr 03, 2025, 07:08 AM EDT
Company Description
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control.
It offers ContraPest, a liquid bait that limits reproduction of male and female rats.
The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech Inc.
| Country | United States |
| IPO Date | Dec 8, 2016 |
| Industry | Chemicals - Specialty |
| Sector | Basic Materials |
| Employees | 23 |
| CEO | Joel L. Fruendt |
Contact Details
Address: 23460 North 19th Avenue Phoenix, Arizona United States | |
| Website | https://www.senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R208 |
| ISIN Number | US81720R5054 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Joel L. Fruendt | Chief Executive Officer, President & Director |
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer & Secretary |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 25, 2025 | D | Filing |
| Mar 13, 2025 | 10-K | Annual Report |
| Mar 12, 2025 | 8-K | Current Report |
| Mar 11, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 12, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jan 10, 2025 | 4 | Filing |
| Jan 10, 2025 | 3 | Filing |
| Jan 10, 2025 | 8-K | Current Report |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |